MICHAEL BISHARA: Open Payments
NPI 1144311044 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 36 payments from 5 companies in 2025. Trend: 2023 $198 · 2024 $270 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $322 |
| Indivior Inc. | 10 | $245 |
| Braeburn Inc. | 8 | $146 |
| Alkermes, Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: CAPLYTA, SUBLOCADE, BRIXADI, ARISTADA, Sunosi.
Industry payments across CA — which companies pay providers there.
